CDH13 and hepatocellular carcinoma: Other research groups have demonstrated that T-cadherin could be upregulated in blood vessels penetrating lung metastases, mouse mammary tumors and human hepatocellular carcinoma with reduced expression of T-cadherin in tumor cells [5,6,13].